← Leaderboards
Carl Grunfeld
University Of California San Francisco
$20,784,045
Attributed
$20,784,045
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2005–11$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$20,784,045 · 7
By mechanism
R01$19,683,577 · 3
U01$970,549 · 1
M01$115,251 · 2
P41$14,668 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Francesca T. Aweeka$9,163,452
- Mark A Jacobson$6,824,928
- Sunil Parikh$7,693,164
- Judith Ann Aberg$20,303,532
- Warner C Greene$31,742,202
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchMetabolismHiv InfectionsProtease InhibitorBody CompositionInsulin Sensitivity /ResistanceGlucose MetabolismAntiaids AgentPharmacologyMagnetic Resonance ImagingPharmaceutical PreparationsBaseAids TherapyMediatingInsulin SecretionDesignAcuteBlood GlucoseBlood LipoproteinHypertriglyceridemiaInsulin ResistanceAdipose TissueAnti-Retroviral Agents
Grant awards (30)
Effects of Antiretroviral Drugs on Metabolism$355,267
R01 · FY2011 · DK · contact PI
FOR THE STUDY OF FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$14,668
P41 · FY2011 · RR · contact PI
Effects of Antiretroviral Drugs on Metabolism$358,855
R01 · FY2010 · DK · contact PI
Effects of Antiretroviral Drugs on Metabolism$362,480
R01 · FY2009 · DK · contact PI
Effects of Antiretroviral Drugs on Metabolism$362,480
R01 · FY2008 · DK · contact PI
HIV Antiretroviral Drugs and Glucose Metabolism$352,013
R01 · FY2007 · DK · contact PI
Fat Redistribution and Metabolic Change in HIV Infection$1,900,266
R01 · FY2006 · HL · contact PI
HIV Antiretroviral Drugs and Glucose Metabolism$362,526
R01 · FY2006 · DK · contact PI
Fat Redistribution and Metabolic Change in HIV Infection$3,192,269
R01 · FY2005 · HL
HIV Antiretroviral Drugs and Glucose Metabolism$371,250
R01 · FY2005 · DK
ACUTE EFFECTS OF HIV PIS ON GLUCOSE DISPOSAL$53,063
M01 · FY2005 · RR
Fat Redistribution and Metabolic Change in HIV Infection$3,315,645
R01 · FY2004 · HL
HIV Antiretroviral Drugs and Glucose Metabolism$371,250
R01 · FY2004 · DK
Acute effects of HIV PIs on glucose disposal$62,188
M01 · FY2004 · RR
Fat Redistribution and Metabolic Change in HIV Infection$2,617,565
R01 · FY2003 · HL
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$500,000
R01 · FY2002 · DK
BIOELECTRICAL IMPEDANCE ANALYSIS HIV+ WOMEN WITH OR WITHOUT WASTING SYNDROME$289,716
U01 · FY2002 · AI
EFFECT OF VIRAL PROTEASE INHIBITOR DRUGS ON METABOLISM$0
M01 · FY2002 · RR
EFFECT OF VIRAL PROTEASE INHIBITOR DRUGS ON METABOLISM$0
M01 · FY2002 · RR
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$316,005
R01 · FY2001 · DK
BIOELECTRICAL IMPEDANCE ANALYSIS HIV+ WOMEN WITH OR WITHOUT WASTING SYNDROME$289,716
U01 · FY2001 · AI
BIOELECTRICAL IMPEDANCE ANALYSIS HIV+ WOMEN WITH OR WITHOUT WASTING SYNDROME$228,401
U01 · FY2001 · AI
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$200,000
R01 · FY2001 · DK
EFFECT OF VIRAL PROTEASE INHIBITOR DRUGS ON METABOLISM$0
M01 · FY2001 · RR
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$2,877,297
R01 · FY2000 · DK
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION$1,868,409
R01 · FY2000 · DK
BIOELECTRICAL IMPEDANCE ANALYSIS HIV+ WOMEN WITH OR WITHOUT WASTING SYNDROME$162,716
U01 · FY2000 · AI
EFFECT OF VIRAL PROTEASE INHIBITOR DRUGS ON METABOLISM$0
M01 · FY2000 · RR
EFFECT OF VIRAL PROTEASE INHIBITOR DRUGS ON METABOLISM$0
M01 · FY2000 · RR
EFFECT OF VIRAL PROTEASE INHIBITOR DRUGS ON METABOLISM$0
M01 · FY2000 · RR